Project Grant HT9425261E058
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a Project Grant totaling $1,528,250 under the Military Medical Research and Development program (CFDA 12.420) to develop a predictive spatial assay designed to eliminate unnecessary therapies in primary ductal carcinoma in situ (DCIS). The award, effective May 1, 2026 through April 30, 2030, supports advanced biomedical research aimed at improving oncologic treatment outcomes through...
- Federal Grant Award Summary The Leland Stanford Junior University received a Project Grant award of $832,270 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025, through June 30, 2028. The award supports high-throughput in vivo lung cancer pharmacogenomics research to be conducted at Stanford's Palo Alto, California facility. This research initiative aligns with the DHA's mission to advance biomedical solutions...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a Project Grant totaling $3,128,801 under the Military Medical Research and Development program (CFDA 12.420) to develop a blood test for measuring sleep deprivation and circadian time. The award, effective June 1, 2025, through May 31, 2028, supports advanced biomedical research directed at transforming healthcare for military service members and the broader public. This research initiative...
- This federal Project Grant award of $4,277,148.00 from the Defense Health Agency under the CFDA Program 12.420 - Military Medical Research and Development supports research to identify molecular predictors of risk and objectively validate the evolution of ductal carcinoma in situ (DCIS). The award, effective September 30, 2023, with an ultimate completion date of September 29, 2027, will be performed at Stanford University. Through this grant, Stanford University will conduct basic,...
- Grant Award Summary The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a $1,054,071 Project Grant under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2028. The award funds research and development activities focused on novel inhibitors of NEMO-like kinase for the treatment of Diamond Blackfan Anemia, a rare blood disorder. Stanford will conduct this research at its Palo Alto, California campus,...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a $4.23 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) for research titled "Advancing Cure Rates for Infantile Acute Lymphoblastic Leukemia." The award, effective June 1, 2025, with a completion date of May 31, 2029, funds basic and applied biomedical research designed to improve therapeutic outcomes for pediatric acute lymphoblastic...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,191,941 to The Leland Stanford Junior University (Stanford University) from July 15, 2023 through July 14, 2027. The purpose of the grant is to conduct research on "Targeting Unusual Nutrient Acquisition Routes of Nutrient-Deprived Cancers." As a highly-regarded private research university, Stanford University has a history of providing...
- This $469,381.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by The Leland Stanford Junior University (Stanford University) to engineer cytotoxic lymphocytes to infiltrate ovarian cancer tumors via metabolite-sensing receptors. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing medical solutions for critical health...
- This $926,400 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to The Leland Stanford Junior University. The grant will fund a 3-year research project to conduct an "Integrated Immunophenotypic Transcriptomic and Epigenomic Characterization of Uterine Mesenchymal Neoplasms with Expert Pathologist Panel Review". The objectives are to advance scientific understanding and develop new treatments for these...
- This $370,866 Formula Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research conducted by The Leland Stanford Junior University, a prominent private research university. The grant will fund a 1-year project to uncover synthetically lethal genes that could be targeted in lung cancer in the presence of protein folding stress, with the goal of transforming healthcare for military service members...
The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a $1,821,750 project grant under the Military Medical Research and Development program (CFDA 12.420) effective May 1, 2026 through April 30, 2030. The grant supports research and development of a predictive spatial assay designed to identify and eliminate unnecessary therapeutic interventions in patients with primary ductal carcinoma in situ (DCIS). This initiative represents part of DHA's broader effort to advance innovative biomedical solutions that improve healthcare outcomes for military service members and the American public through precision medicine approaches in oncology. The four-year research project, to be conducted at Stanford University's Palo Alto, California facility, delivers hypothesis-driven translational research focused on cancer diagnostic innovation. The work falls within DHA's portfolio of oncology and precision medicine research priorities and involves the development of a spatial biomarker assay intended to guide clinical decision-making and reduce unnecessary treatment burden for DCIS patients. As a leading federal research partner, Stanford University brings established capabilities in advanced biomedical research and medical device development to address this critical healthcare challenge within the military medical research priorities.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.8m | 4/2/26 |